Disorazole Gene cluster

Information

  • Research Project
  • 6735274
  • ApplicationId
    6735274
  • Core Project Number
    R43CA105615
  • Full Project Number
    1R43CA105615-01
  • Serial Number
    105615
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2004 - 20 years ago
  • Project End Date
    5/31/2005 - 19 years ago
  • Program Officer Name
    FU, YALI
  • Budget Start Date
    6/1/2004 - 20 years ago
  • Budget End Date
    5/31/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/21/2004 - 20 years ago
Organizations

Disorazole Gene cluster

[unreadable] DESCRIPTION (provided by applicant): The long-range goal of our research program is to discover novel disorazole analogs and to develop one of them into a useful antitumor drug. Although disorazole A is a potent cytotoxic agent, with IC50's below the nanomolar range (0.12 to 0.63 nM), novel compounds with good therapeutic index should be developed. In order to initiate a systematic program of chemical modifications on disorazole A, we will need unlimited amounts of the starting material. Sorangium cellulosum strain So ce12, the natural producer of disorazoles, only makes small amounts of this family of compounds (less than 100 mg/I) and it is a very slow growing microorganism (16 h doubling time). Moreover, the genetics of this bacterium has not yet been developed, which restricts enormously the possibility of generating analogs through genetic modification of the disorazole gene cluster. In order to break through these limitations we will pursuit the following Specific Aims. (1) Identify the disorazole biosynthetic genes by following a transposon-based approach. First, isolating non-producing mutants by HPLC analysis of the growth medium, then cloning and sequencing the genome sequences flanking the integrated transposon. Alternatively, we will identify the gene cluster by screening a cosmid or a BAC library with probes that recognize distinctive features of the disorazole genes. (2) Sequencing the complete gene cluster from a cosmid or a BAC containing the entire region. (3) Production of disorazole in the heterologous host Myxococcus xanthus by introducing the entire disorazole gene cluster. This microorganism grows very well in large fermenters and has a robust genetic system. Achievement of these objectives will enable the production of large amounts of disorazole A1 for further exploration of its antitumor properties and modification of them to improve the pharmacological properties by changing the chemical structure of the compound through genetic engineering and chemical synthesis. [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    KOSAN BIOSCIENCES, INC.
  • Organization Department
  • Organization DUNS
    932981319
  • Organization City
    HAYWARD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94545
  • Organization District
    UNITED STATES